## Abstract There has been substantial advances in our understanding of the nature of the Hodgkin/Reed–Sternberg (H/RS) cell in recent years. There is now compelling evidence that the H/RS cells in the vast majority of cases of classical Hodgkin's disease (CHD) are derived from the B‐cell lineage a
Detection of ebv gene expression in reed-sternberg cells of Hodgkin's disease
✍ Scribed by Tzyy-Choou Wu; Risa B. Mann; Patricia Charache; S. Diane Hayward; Steve Staal; Beverly C. Lambe; Richard F. Ambinder
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- French
- Weight
- 843 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
EBV DNA has been detected by Southern blot hybridization in 20‐25% of Hodgkin's disease tumor specimens and localized to the Reed‐Sternberg cells by in situ hybridization. In the present investigation we used a ^3^H‐labelled EBER I anti‐sense RNA for in situ hybridization of archival formalinfixed paraffin‐embedded Hodgkin's disease specimens previ ously shown by Southern Blot hybridization to be EBV‐positive. In 6 of 8 specimens neoplastic cells showed an intense signal in virtually all of the tumor cells. The background lym phocytes, eosinophils, plasma cells and histiocytes did not demonstrate significant hybridization. In each case hybridiza tion tended to spare the nucleoli. Hybridization was detected in specimens with histologies of mixed cellularity and nodular sclerosis. The intensity of signal relative to background is bet ter than that in previous studies utilizing ^35^S‐labelled large internal repeat probes for EBV in Reed‐Sternberg cells. The exposure time is one week in contrast to the 4‐5 weeks reported by others for detection of EBV in Hodgkin's disease. Both increased relative intensity and shorter exposure re quirements may be attributed to the very high number of EBER transcripts in the target cells. The demonstration that EBER I is expressed is consistent with a role for EBV in growth regulation of Reed‐Sternberg cells and suggests that the virus is not merely a silent passenger in Hodgkin's disease.
📜 SIMILAR VOLUMES
Molecular genetic analysis of rearranging antigen-receptor genes in non-Hodgkin's lymphomas has revealed the clonality and lineage in the majority of cases. In an analogous approach, we sought to apply gene rearrangement analysis to Hodgkin's disease to understand better the clonality and origin of
## Epstein-Barr virus (EBV) is detected in Hodgkin and Reed-Sternberg (HRS) cells in up to 50% of patients with Hodgkin's disease (HD). HD patients have been reported to express high serum titers against EBV antigens, even prior to the diagnosis of HD. Patients with high serum titers have a poorer
## Abstract Nonisotopic in situ hybridization has been used to investigate the role of Epstein‐Barr virus (EBV) in the aetiology of pediatric Hodgkin's disease. Sections from 24 cases arising in children under the age of 15 years were hybridised with digoxigenin‐labelled probes for both EBV and cyt
Hodgkin and Reed-Sternberg cells are considered to represent the malignant fraction in Hodgkin's disease. Several studies have shown that the Hodgkin and Reed-Sternberg cells are chromosomally abnormal, but genetic data about the morphologically normal cell population in Hodgkin's disease are very l
## Abstract Hodgkin's and Reed/Sternberg (HRS) cells, the tumour cells in classical Hodgkin's lymphoma (HL), represent transformed B cells in nearly all cases. The detection of destructive somatic mutations in the rearranged immunoglobulin (Ig) genes of HRS cells in classical HL indicated that they